Loading...

Asset Growth And Platform Expansion Will Drive Measured Wealth Management Upside

Published
10 Nov 24
Updated
10 Mar 26
Views
341
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
22.4%
7D
-1.3%

Author's Valuation

CA$68.338.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 10 Mar 26

Fair value Increased 0.49%

GWO: Capital Returns And Cautious Sector Outlook Will Shape Medium Term Re Rating

Great West Lifeco's analyst fair value estimate has inched up by about CA$0.33 to CA$68.33, reflecting a mix of higher and lower price targets across the Street as analysts balance updated views on growth, margins, and sector conditions.

Analyst Commentary

Street research on Great West Lifeco is clustered around small upward and downward price target moves, with most firms keeping neutral to moderately positive ratings. For you, that means the focus is less on big rating changes and more on how analysts are fine tuning expectations around valuation and execution.

Bullish Takeaways

  • Several bullish analysts have lifted price targets into the C$70 to C$73 range, which signals confidence that the current share price leaves room for upside if management delivers on its plans.
  • Positive ratings paired with higher targets suggest that some analysts are comfortable with how the company is executing and see its fundamentals as supportive of a higher fair value anchor.
  • Where targets have moved up by a few dollars, bullish analysts appear to be acknowledging potential for solid capital strength and cash generation to support earnings quality and shareholder returns.
  • References to being cautiously optimistic on life insurers heading into 2026 indicate that, within the sector, Great West Lifeco is still viewed as a viable way to gain exposure if conditions remain constructive.

Bearish Takeaways

  • Some bearish analysts have trimmed price targets in the C$60s while keeping neutral ratings, which points to concerns that the shares may already reflect much of the near term execution story.
  • Comments about headwinds such as spread compression and technology spend highlight worries that profitability could be pressured if investment income or expenses move against expectations.
  • The clustering of ratings around Sector Perform or Market Perform suggests that a portion of the Street sees the risk reward balance as fairly even, with limited justification for a strongly bullish stance at current levels.
  • Where targets are only adjusted by C$1 to C$2, cautious analysts may be signaling that visibility on growth and margins is constrained, so they are reluctant to assign materially higher valuations without clearer evidence.

What's in the News

  • The Board of Directors approved a quarterly dividend of $0.67 per common share, a 10% increase per share, payable March 31, 2026, to shareholders of record as of March 3, 2026 (Key Developments).
  • From October 1, 2025 to December 31, 2025, the company repurchased 15,145,346 shares for $929 million, representing 1.65% of shares, bringing total repurchases under the January 2, 2025 buyback to 28,438,145 shares or 3.07% for $1,625 million (Key Developments).
  • Great West Lifeco announced a normal course issuer bid that allows repurchases of up to 20,000,000 common shares, or 2.2% of issued share capital. All repurchased shares are to be cancelled. The bid runs until January 5, 2027 and follows a share count of 907,158,831 common shares as of December 23, 2025 (Key Developments).
  • The Board of Directors authorized a new buyback plan on January 2, 2026, adding another capital return tool alongside existing dividend payments (Key Developments).
  • A special or extraordinary shareholders meeting is scheduled for May 7, 2026 in Winnipeg, Manitoba, giving investors a set date to watch for company level proposals and updates (Key Developments).

Valuation Changes

  • Fair Value: CA$68.33, up modestly from CA$68.00, reflecting a small recalibration of the model.
  • Discount Rate: Unchanged at 6.254%, indicating no adjustment to the required return used in the valuation.
  • CA$ Revenue Growth: Assumption raised from 6.77% to 7.69%, pointing to slightly higher expectations for revenue.
  • Net Profit Margin: Assumption trimmed from 12.36% to 12.00%, signaling a small pullback in projected profitability.
  • Future P/E: Multiple nudged up from 12.79x to 12.89x, a slight increase in the earnings valuation applied to the shares.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Strong demographic trends and global market expansion position the company for sustained growth in retirement and wealth management solutions.
  • Digital transformation and capital-light business expansion are set to drive efficiency, stable earnings, and improved returns on equity.
  • Structural industry headwinds, increasing competition, business model shifts, and execution risk on digital transformation threaten Great-West Lifeco's organic growth, margins, and earnings diversity.

Catalysts

About Great-West Lifeco
    Engages in the life and health insurance, retirement savings, wealth and asset management, and reinsurance businesses in Canada, the United States, and Europe.
What are the underlying business or industry changes driving this perspective?
  • Strong demographic tailwinds-including population aging and rising life expectancy-are expected to increase demand for retirement and wealth management solutions, positioning Great-West Lifeco to capture greater top-line revenue growth as their addressable market expands globally.
  • Continued digital transformation initiatives, including the adoption of AI and process automation, are expected to materially enhance operational efficiency, supporting a structurally lower cost base and improving net margins over the medium term.
  • Expansion of fee-based, capital-light wealth and asset management businesses (such as Empower) provides more stable, recurring earnings and higher return on equity, leading to more predictable and higher-quality earnings growth.
  • Significant runway for revenue growth exists from capturing "money in motion" through rollovers/crossovers and increased product penetration among Empower's large participant base, which is likely to boost both asset-based and participant-based fee income.
  • The company's substantial share repurchase program and disciplined capital allocation, underpinned by robust cash generation and a strengthened balance sheet, are poised to drive higher earnings per share and return on equity over time, further closing the valuation gap.

Great-West Lifeco Earnings and Revenue Growth

Great-West Lifeco Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Great-West Lifeco's revenue will grow by 5.8% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 10.6% today to 10.3% in 3 years time.
  • Analysts expect earnings to reach CA$4.3 billion (and earnings per share of CA$4.88) by about September 2028, up from CA$3.7 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting CA$4.9 billion in earnings, and the most bearish expecting CA$3.8 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 14.2x on those 2028 earnings, up from 13.6x today. This future PE is greater than the current PE for the CA Insurance industry at 13.8x.
  • Analysts expect the number of shares outstanding to grow by 0.1% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.97%, as per the Simply Wall St company report.

Great-West Lifeco Future Earnings Per Share Growth

Great-West Lifeco Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Long-term demographic shifts, including elevated participant outflows as baby boomers retire (and a persistent 0.5%-1% annual participant outflow for 5–6 years), may suppress organic growth in key U.S. Retirement businesses, pressuring net new asset inflows and associated fee-based revenues.
  • Growing competition and fee compression in workplace retirement and wealth management (evidenced by zero-fee index fund launches and greater reliance on fixed per-participant fees over asset-based fees), could erode average fee income from assets, weighing on revenue and net margins over the long term.
  • Strategic exit from U.S. traditional life mortality reinsurance, due to an inability to achieve target returns and increasingly unattractive market dynamics, signals risks associated with business model adaptation and may limit future earnings diversity, especially if new capital solutions and risk solutions do not scale as expected.
  • Ongoing exposure to credit events, like the negative impact from U.K. water utility bond holdings, highlights the risk that idiosyncratic or structural credit losses in global portfolios, as well as potential economic or market volatility, could adversely affect investment returns-impacting profitability, earnings, and capital ratios.
  • Large-scale investment in digital transformation and efficiency initiatives ($250–$300 million post-tax charges), while intended to reduce expense ratios and enhance scalability, carries execution risk; failure to deliver targeted efficiency gains could leave the company exposed to above-target operating expenses, ultimately impacting net margins and long-term earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of CA$55.0 for Great-West Lifeco based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$61.0, and the most bearish reporting a price target of just CA$45.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be CA$41.6 billion, earnings will come to CA$4.3 billion, and it would be trading on a PE ratio of 14.2x, assuming you use a discount rate of 6.0%.
  • Given the current share price of CA$54.55, the analyst price target of CA$55.0 is 0.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Great-West Lifeco?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives